Proteomic and Targeted Metabolomic Studies on a Silkworm Model of Parkinson's Disease.

Parkinson's disease (PD) is a chronic and progressive movement disorder that is characterized by the loss of dopaminergic neurons in the brain. Animal models of PD have become very popular in the past two decades to understand the etiology, pathology, and molecular and cellular pathways associated with PD. In this study, we report the first neurotoxin-induced silkworm model for PD by chronic feeding with 6-hydroxydopamine (6-OHDA) and explore the possible molecular mechanisms associated with PD using proteomic and targeted metabolomic approaches. Although silkworm is phylogenetically distant from humans and rats, 6-OHDA treatment produced similar PD phenotypes, including motor dysfunction, dopaminergic neuron degeneration, and decreased levels of dopamine. Major neurotransmitters in the silkworm head tissue were profiled, revealing key molecules implicating neurodegenerative disorder. Proteomics analysis revealed a major downregulation of nearly 50 structural proteins constituting cuticles and microfilaments, indicating mechanical damage in the silkworm tissues. The results suggest that 6-OHDA treatment could induce PD-like symptoms in silkworms and activate similar proteomic and metabolic pathways to those in rats or higher animals. This study demonstrates the feasibility and value of the silkworm-based PD model, which may provide important clues for understanding the molecular and cellular mechanisms underlying PD. The mass spectrometry raw files have been deposited to iProx via the project ID IPX0004206000.

[1]  B. Melichar,et al.  Determination of one year stability of lipid plasma profile and comparison of blood collection tubes using UHPSFC/MS and HILIC-UHPLC/MS. , 2020, Analytica chimica acta.

[2]  K. Jóźwiak,et al.  Recent developments of bioanalytical methods in determination of neurotransmitters in vivo. , 2019, Journal of pharmaceutical and biomedical analysis.

[3]  Ashokkumar Balasubramaniem,et al.  Oxidative stress response, epigenetic and behavioral alterations in Caenorhabditis elegans exposed to organophosphorus pesticide quinalphos , 2019, Biocatalysis and Agricultural Biotechnology.

[4]  Y. Iwata,et al.  Kynurenine pathway in depression: A systematic review and meta-analysis , 2018, Neuroscience & Biobehavioral Reviews.

[5]  Ying Lin,et al.  Wild Silkworm Cocoon Contains More Metabolites Than Domestic Silkworm Cocoon to Improve Its Protection , 2017, Journal of insect science.

[6]  G. Akpinar,et al.  Proteomic studies associated with Parkinson’s disease , 2017, Expert review of proteomics.

[7]  G. Jékely,et al.  Ancient coexistence of norepinephrine, tyramine, and octopamine signaling in bilaterians , 2016, BMC Biology.

[8]  H. Bono,et al.  Can the silkworm (Bombyx mori) be used as a human disease model? , 2016, Drug discoveries & therapeutics.

[9]  H. Qing,et al.  Differential expression of synaptic proteins in unilateral 6‐OHDA lesioned rat model—A comparative proteomics approach , 2014, Proteomics.

[10]  H. Bono,et al.  Identification of Key Uric Acid Synthesis Pathway in a Unique Mutant Silkworm Bombyx mori Model of Parkinson’s Disease , 2013, PloS one.

[11]  P. Barone,et al.  Neurotransmission in Parkinson’s disease: beyond dopamine , 2010, European journal of neurology.

[12]  Ronald L. Davis,et al.  Eight Different Types of Dopaminergic Neurons Innervate the Drosophila Mushroom Body Neuropil: Anatomical and Physiological Heterogeneity , 2009, Front. Neural Circuits.

[13]  J. Klose,et al.  Proteome analysis of ventral midbrain in MPTP‐treated normal and L1cam transgenic mice , 2008, Proteomics.

[14]  Detlev Boison,et al.  Adenosine as a neuromodulator in neurological diseases. , 2008, Current opinion in pharmacology.

[15]  X. Pu,et al.  Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease , 2007, Proteomics. Clinical applications.

[16]  H. Reichert,et al.  Insights into the urbilaterian brain: conserved genetic patterning mechanisms in insect and vertebrate brain development , 2005, Heredity.

[17]  Steven E. Hyman Neurotransmitters , 2005, Current Biology.

[18]  O. Hobert,et al.  Functional mapping of neurons that control locomotory behavior in Caenorhabditis elegans. , 2003, Journal of neurobiology.

[19]  W. Bender,et al.  A Drosophila model of Parkinson's disease , 2000, Nature.

[20]  U. Ungerstedt,et al.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.